GlassScriptPhysician profile
Gregory S Schenk
NPI 1649264185
$8,327.95
in general payments reported to CMS, 2019-2025
43 companies · $1,376 in 2025
The $1,376 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2020: $287 · 2021: $1,667 · 2022: $1,174 · 2023: $1,142 · 2024: $1,583 · 2025: $1,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,915 · Education: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,914.70 |
| Education | $185.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,264.72 | 2019-2025 | Erleada, Akeega |
| Intuitive Surgical, INC. | $666.99 | 2019-2021 | |
| Astellas Pharma US INC | $553.13 | 2019-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $493.50 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $439.67 | 2023-2025 | Orgovyx, Gemtesa |
| Progenics Pharmaceuticals, INC. | $415.51 | 2022-2025 | Pylarify |
| Procept Biorobotics Corporation | $407.14 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Urovant Sciences INC | $297.56 | 2021-2022 | |
| Urogen Pharma, INC. | $296.88 | 2021-2025 | |
| Boston Scientific Corporation | $229.73 | 2019-2024 | Rezum Generator |
| Axonics, INC. | $229.45 | 2022-2023 | Axonics |
| Tempus Ai, INC | $219.65 | 2024-2025 | Xt Cdx |
| Medtronic, INC. | $210.97 | 2022 | |
| Ferring Pharmaceuticals INC. | $206.91 | 2024-2025 | Adstiladrin |
| Blue Earth Diagnostics | $198.88 | 2019-2024 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $175.82 | 2022-2025 | Speedicath |
| Myovant Sciences INC. | $170.39 | 2021 | |
| Merck Sharp & Dohme LLC | $159.25 | 2021-2025 | Keytruda, Welireg, Keytruda Qlex |
| Antares Pharma, INC. | $157.77 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Photocure INC | $157.31 | 2019-2022 | |
| Histosonics, INC. | $150.00 | 2025 | |
| Dendreon Pharmaceuticals LLC | $137.74 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.77 | 2019-2025 | |
| Bioprotect Medical, INC. | $123.66 | 2024 | Bioprotect Balloon Implant System |
| Neotract INC. | $109.55 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $97.76 | 2020-2022 | |
| Accord Healthcare, INC. | $58.30 | 2023-2024 | |
| Dentsply Ih Ab | $56.82 | 2023-2025 | Lofric, Lofric |
| Astrazeneca Pharmaceuticals LP | $53.18 | 2025 | Lynparza |
| Immunitybio, INC. | $51.74 | 2024-2025 | |
| Tolmar, INC. | $51.22 | 2024-2025 | Jatenzo, Eligard |
| Myriad Genetic Laboratories, INC. | $49.80 | 2021 | |
| Abbvie INC. | $49.59 | 2021-2022 | |
| Teleflex LLC | $41.50 | 2024-2025 | Urolift, Deknatel |
| Hollister Incorporated | $41.15 | 2023-2024 | Onli, Infyna Chic, Vapro |
| Novartis Pharmaceuticals Corporation | $34.60 | 2025 | |
| Rochester Medical Corporation | $31.87 | 2020-2021 | |
| Amgen INC. | $22.29 | 2020 | |
| Acerus Pharmaceuticals Corporation | $19.58 | 2020 | |
| Verity Pharmaceuticals INC. | $18.65 | 2025 | Tlando |
| Endo Pharmaceuticals INC. | $18.44 | 2019 | |
| Bluewind Medical | $17.91 | 2025 | Revi |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Schenk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.